+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Immune Health Supplements Market by Distribution Channel, Form, Ingredient - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674768
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Immune Health Supplements Market grew from USD 67.39 billion in 2024 to USD 72.77 billion in 2025. It is expected to continue growing at a CAGR of 7.84%, reaching USD 106.02 billion by 2030.

Unveiling the Dynamic Immune Health Supplements Arena

The global focus on immune health has accelerated in recent years as consumers increasingly prioritize preventative wellness solutions. Rising awareness of pathogenic threats, demographic shifts toward aging populations, and evolving lifestyle concerns have converged to position immune health supplements at the forefront of nutraceutical innovation. In response, manufacturers and brands have expanded their portfolios to encompass a spectrum of formulations and ingredients designed to bolster the body’s natural defenses.

Against this backdrop, the immune health supplements arena has matured beyond simple vitamin C tablets into a diversified ecosystem that integrates probiotics, botanical extracts, trace minerals, and advanced delivery systems. This expansion reflects both consumer demand for multifunctional health benefits and emerging scientific validation for novel compounds. As a result, industry stakeholders are challenged to navigate a complex interplay of regulatory standards, supply chain constraints, and evolving consumer preferences.

This executive summary offers an in-depth exploration of the key drivers reshaping the market landscape, the strategic responses by industry leaders, and actionable insights for organizations seeking to capitalize on growth opportunities. By examining transformative shifts, tariff impacts, segmentation dynamics, regional variances, and competitive intelligence, this overview equips decision-makers with the knowledge required to formulate robust strategies in an increasingly competitive environment.

Navigating Revolutionary Shifts in Immune Supplement Strategies

The immune health supplements market has undergone radical transformation as traditional models give way to integrated, consumer-centric approaches. Personalized nutrition platforms now leverage digital health data to recommend customized formulations, blending multivitamin complexes with targeted botanical extracts like elderberry and zinc chelates. These AI-driven recommendations are augmented by telehealth consultations, creating a seamless path from diagnosis to supplementation.

Simultaneously, the industry has shifted from single-ingredient offerings toward synergistic combinations. Probiotic strains such as bifidobacterium and lactobacillus are paired with vitamin C and multivitamin blends to deliver complementary benefits for gut-immune axis support. Innovations in softgel and microencapsulation technologies have elevated bioavailability, enabling premium pricing tiers and enhanced consumer loyalty.

Moreover, distribution strategies have evolved rapidly. Brand websites and e-commerce marketplaces coexist with traditional pharmacy drugstores, while emerging e-pharmacies facilitate direct-to-consumer prescription-like fulfillment. These channels are shaping omnichannel experiences that blend digital engagement with in-store education. As regulatory frameworks adapt to these new models, industry players must remain agile to harness the momentum of these transformative shifts.

Assessing 2025 US Tariffs on Immune Health Supply Chains

The introduction of new United States tariffs in 2025 has exerted significant pressure on the immune health supplements supply chain, prompting recalibration across sourcing, manufacturing, and pricing strategies. Import duties on botanical inputs such as elderberry extract and key micronutrients have increased production costs for many brands. At the same time, tariffs targeting probiotic imports from European regions have disrupted established partnerships with overseas cultivators, forcing companies to diversify supplier portfolios or absorb cost escalation.

Consequently, some manufacturers have accelerated investments in domestic production capabilities and alternative ingredient sourcing. By forging alliances with regional growers of zinc-rich horticultural outputs and developing fermentation processes for probiotic strains within local facilities, firms can mitigate exposure to international trade flux. Nonetheless, these transitions require capital investment and operational adjustments that may impact short-term margins.

To preserve competitive pricing and maintain market share, organizations are optimizing logistics through nearshoring initiatives and collaborative distribution agreements. They are also re-evaluating product formulations to identify ingredients with lower tariff incidence while safeguarding efficacy. Overall, the 2025 tariff environment has catalyzed a strategic pivot toward supply chain resilience, compelling industry participants to embrace flexibility and innovation in the face of evolving trade policies.

Dissecting Distribution, Format, and Ingredient Dynamics

Segmenting the market by distribution channel reveals that consumers are increasingly gravitating toward online retail, where brand websites, e-commerce marketplaces, and e-pharmacies offer seamless ordering and subscription models. Despite this digital surge, traditional direct sales and the pharmacy drugstore network-both chain and independent establishments-retain influence through in-person counseling and established consumer trust. Specialty stores command niche followings for curated formulations, while supermarket hypermarkets drive broad-access sales through value-driven bundles and promotional campaigns.

When examining product forms, capsules continue to dominate due to convenience and portability, yet softgels and liquids are gaining traction among consumers seeking rapid absorption and functional versatility. Tablets remain a cost-effective staple, whereas powder formulations appeal to wellness enthusiasts who blend supplements into smoothies and beverages. Chewables have carved out a growing segment among younger demographics who value palatable dosing experiences.

Ingredient segmentation highlights vitamin C and zinc as perennial favorites for basic immune support, while multivitamin blends appeal to those seeking comprehensive daily coverage. Elderberry extract has surged in popularity as a natural antioxidant, and probiotic strains bifidobacterium and lactobacillus are increasingly valued for their role in gut-mediated immunity. These ingredient trends underscore the market’s evolution toward both foundational and specialized immune health solutions.

Exploring Regional Demand and Regulatory Landscapes

Regional consumption patterns in the Americas are anchored by strong demand for clinically validated formulations and innovative delivery systems. Health-conscious North American consumers prioritize evidence-based claims, driving investment in clinical trials and third-party certifications. Meanwhile, Latin American markets are experiencing rising adoption of immune supplements as disposable incomes grow and urban healthcare infrastructures expand.

In Europe, Middle East & Africa, regulatory harmonization across the European Union has fostered a competitive landscape where stringent health claims necessitate robust scientific substantiation. Concurrently, Middle Eastern markets leverage traditional botanical knowledge, integrating local herbs into modern supplement formats. African markets present both challenges and opportunities, with nascent urban health trends coexisting alongside limited distribution networks and evolving regulatory frameworks.

Across the Asia-Pacific region, rapid economic growth and increasing health awareness are propelling demand for both established and novel supplements. Traditional medicine systems in China, India, and Southeast Asia intersect with Western nutraceutical paradigms, resulting in hybrid formulations that resonate with local consumer preferences. E-commerce penetration in these markets further accelerates access to global brands, fueling a dynamic competitive environment.

Profiling Industry Leaders and Their Growth Strategies

Leading firms in the immune health supplements arena are distinguishing themselves through strategic product diversification and targeted marketing campaigns. Industry frontrunners have expanded their portfolios to include specialized offerings such as pediatric chewables, plant-based softgels, and microencapsulated probiotic blends, reinforcing their commitment to meeting diverse consumer needs. These companies prioritize research collaborations with universities and contract manufacturing organizations to accelerate innovation cycles and validate efficacy claims.

Strategic partnerships with e-commerce platforms and specialty retailers have enhanced market penetration, while loyalty programs and subscription services have deepened customer engagement. Sustainability initiatives, including eco-friendly packaging and responsibly sourced ingredients, have become key differentiators as environmentally conscious consumers scrutinize brand ethics. Moreover, mergers and acquisitions among mid-tier players are reshaping the competitive landscape, consolidating market share and enabling economies of scale.

By leveraging advanced analytics, these organizations track consumer sentiment and purchase behavior in real time, informing iterative updates to formulations and messaging. Their agile approach ensures responsiveness to emerging trends and regulatory shifts, cementing their positions as market leaders poised for sustained growth.

Strategic Roadmap for Leadership and Resilience

To thrive in the evolving immune health supplements market, industry leaders should prioritize supply chain agility by diversifying sourcing strategies and investing in nearshore manufacturing capabilities. Cultivating direct relationships with agricultural suppliers of key botanicals and micronutrient producers will minimize exposure to geopolitical volatility and tariff fluctuations. Simultaneously, partnering with contract research organizations to conduct robust clinical validations will reinforce product credibility and satisfy increasingly stringent regulatory requirements.

Embracing digital transformation is critical: companies must refine e-commerce experiences, leverage AI-driven personalization engines, and integrate telehealth consultations to establish comprehensive wellness ecosystems. Developing subscription-based models can enhance customer retention by offering curated supplement regimens and adaptive dosing plans informed by consumer feedback loops. Sustainability commitments should extend beyond packaging into traceability initiatives that document ingredient provenance and carbon footprints.

Finally, cultivating strategic alliances with retail pharmacies and specialized wellness centers will broaden distribution and reinforce consumer trust. By balancing digital and brick-and-mortar channels, leaders can create omnichannel synergies that optimize brand visibility and bolster long-term loyalty. These recommendations will equip organizations to navigate market complexities and deliver differentiated value to health-conscious consumers.

Methodological Framework Underpinning the Analysis

The findings in this report are derived from a rigorous, multi-pronged research methodology that combines extensive secondary research with targeted primary investigations. Esteemed industry databases, peer-reviewed journals, and official trade publications were analyzed to establish baseline market parameters and identify emerging trends. These insights were complemented by in-depth interviews with key stakeholders, including senior executives at leading supplement manufacturers, regulatory experts, and major distribution partners.

Quantitative data was collected through a structured survey distributed to a representative sample of retail and healthcare channels, capturing real-time sales performance and consumer preference metrics. Qualitative insights were gleaned from expert roundtables and triangulated against proprietary trade statistics to ensure robust validation. Throughout the process, data triangulation techniques were employed to reconcile discrepancies and bolster the reliability of conclusions.

Ethical standards and confidentiality protocols were strictly observed during data collection, and all forecasts and analyses underwent peer review by subject-matter specialists. This comprehensive approach ensures that the strategic recommendations and market insights presented are grounded in verifiable evidence and offer actionable value for decision-makers operating in the immune health supplements domain.

Synthesis of Insights and Strategic Imperatives

This executive summary has illuminated the dynamic forces shaping the immune health supplements market, from transformative product innovations and distribution evolutions to the significant repercussions of new US tariffs. By dissecting segmentation patterns and regional disparities, we have underscored the importance of tailored strategies that resonate with diverse consumer cohorts and navigate complex regulatory landscapes. Competitive intelligence reveals how leading players are leveraging clinical validation, sustainable practices, and digital platforms to fortify their market positions.

As the industry advances, agility and evidence-based decision making will serve as cornerstones of enduring success. Organizations that invest in supply chain resilience, forge strategic collaborations, and harness data-driven insights will be poised to capitalize on growth opportunities and mitigate emergent risks. The convergence of personalized nutrition, omnichannel distribution, and rigorous scientific substantiation promises to redefine the contours of immune health solutions in the years ahead.

In closing, this analysis offers a strategic lens through which to view the evolving ecosystem and paves the way for informed action. Stakeholders equipped with these insights can confidently chart their course and drive innovation that meets the evolving expectations of health-focused consumers.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Distribution Channel
    • Direct Sales
    • Online Retail
      • Brand Website
      • E Commerce Marketplace
      • E Pharmacies
    • Pharmacy Drugstore
      • Chain Pharmacy
      • Independent Pharmacy
    • Specialty Stores
    • Supermarket Hypermarket
  • Form
    • Capsule
    • Chewable
    • Liquid
    • Powder
    • Softgel
    • Tablet
  • Ingredient
    • Elderberry Extract
    • Multivitamin Blend
    • Probiotic Strains
      • Bifidobacterium
      • Lactobacillus
    • Vitamin C
    • Zinc
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Amway Corp
  • Herbalife Nutrition Ltd
  • Bayer AG
  • Nestlé Health Science S.A.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Reckitt Benckiser Group plc
  • GNC Holdings LLC
  • Pharmavite LLC
  • The Bountiful Company

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immune Health Supplements Market, by Distribution Channel
8.1. Introduction
8.2. Direct Sales
8.3. Online Retail
8.3.1. Brand Website
8.3.2. E Commerce Marketplace
8.3.3. E Pharmacies
8.4. Pharmacy Drugstore
8.4.1. Chain Pharmacy
8.4.2. Independent Pharmacy
8.5. Specialty Stores
8.6. Supermarket Hypermarket
9. Immune Health Supplements Market, by Form
9.1. Introduction
9.2. Capsule
9.3. Chewable
9.4. Liquid
9.5. Powder
9.6. Softgel
9.7. Tablet
10. Immune Health Supplements Market, by Ingredient
10.1. Introduction
10.2. Elderberry Extract
10.3. Multivitamin Blend
10.4. Probiotic Strains
10.4.1. Bifidobacterium
10.4.2. Lactobacillus
10.5. Vitamin C
10.6. Zinc
11. Americas Immune Health Supplements Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Immune Health Supplements Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Immune Health Supplements Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Amway Corp
14.3.2. Herbalife Nutrition Ltd
14.3.3. Bayer AG
14.3.4. Nestlé Health Science S.A.
14.3.5. Pfizer Inc.
14.3.6. GlaxoSmithKline plc
14.3.7. Reckitt Benckiser Group plc
14.3.8. GNC Holdings LLC
14.3.9. Pharmavite LLC
14.3.10. The Bountiful Company
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. IMMUNE HEALTH SUPPLEMENTS MARKET MULTI-CURRENCY
FIGURE 2. IMMUNE HEALTH SUPPLEMENTS MARKET MULTI-LANGUAGE
FIGURE 3. IMMUNE HEALTH SUPPLEMENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. IMMUNE HEALTH SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. IMMUNE HEALTH SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMMUNE HEALTH SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY E COMMERCE MARKETPLACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY E PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY CHEWABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOFTGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ELDERBERRY EXTRACT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MULTIVITAMIN BLEND, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY VITAMIN C, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ZINC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 51. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 52. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 54. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 57. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 59. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 60. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 86. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 88. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 89. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 91. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 92. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 94. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 97. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 100. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 101. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 103. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 104. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 106. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 107. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 108. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 109. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 110. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 112. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 113. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 114. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 115. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 118. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 121. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 136. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 137. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 139. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 146. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 148. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 149. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 150. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 151. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 152. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 154. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 155. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 156. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 157. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 160. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 161. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 162. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 163. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 170. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 172. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 173. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 174. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 175. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 176. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 178. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 180. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 181. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 188. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 190. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 191. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 192. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 193. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 194. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 196. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 197. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 198. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 199. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 202. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 203. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 204. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 205. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 213. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 215. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 216. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 217. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 218. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 219. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 221. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 222. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 223. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 224. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 225. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 227. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 228. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 229. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 230. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 249. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 251. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 252. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 253. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 254. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 272. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY DRUGSTORE, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 283. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 284. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAINS, 2018-2030 (USD MILLION)
TABLE 285. IMMUNE HEALTH SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 286. IMMUNE HEALTH SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Immune Health Supplements market report include:
  • Amway Corp
  • Herbalife Nutrition Ltd
  • Bayer AG
  • Nestlé Health Science S.A.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Reckitt Benckiser Group plc
  • GNC Holdings LLC
  • Pharmavite LLC
  • The Bountiful Company

Methodology

Loading
LOADING...

Table Information